7,10—二芳基—六氢（四氢）苯并[C]吖啶—8—酮的合成

吖啶及吖啶酮类化合物具有广泛的药理活性,其中许多化合物具有明显的杀菌、抗炎、增强记忆、镇痛和抗癌等活性。如早年开发的抗癌药物山柚柑碱(Acronycine)就具有显著的抗癌作用,且抗瘤谱较广。近年来抗癌新药安吖啶(Amsacrime)在临床上用于治疗急性白血病收到疗效后,对吖啶及吖啶酮衍生物的合成及抗癌活性研究日渐增多。已测定了一些化合物     

6，7-二甲氧亚甲基-3-硫杂-1(2H，4H)吖啶酮的Beckmann重排及硫杂吖啶并六员杂环的合成

本工作首次完成了6,7-二氧亚甲基-3-硫杂-1(2H,4H)吖啶及其衍生物的合成。     

6,7-二氧亚甲基-3-硫杂-1(2H,4H)吖啶酮的Beckmann重排及硫杂吖啶并六员杂环的合成

吖啶类化合物是一类颇受人们注意的抗疟药物,具有抗癌活性的吖啶合成也引起了有机化学工作者的极大兴趣。虽然对吖啶的化学已经进行了相当深入的研究,但硫杂吖啶酮     

离子液体中一步合成14-芳基-1,6,7,14-四氢二苯并[a, i]吖啶-1,6-二酮衍生物

室温条件下在离子液体[bmim]BF4中合成了14-芳基-1,6,7,14-四氢二苯并[a, i]吖啶-1,6-二酮类衍生物,该方法具有产率高,反应介质可回收使用,反应底物范围广,反应时间短,操作简单等优点。     

二氢和四氢-2-芳基-4-甲基(1.5)苯并硫氮杂(艹卓)的构象分析(Ⅱ)

在前文的基础上,又进一步研究了2-芳基-4-甲基(1.5)苯并硫氮杂(艹卓)的光谱和构象分析。硼氢化钠对二氢化物的还原具有高度立体选择性,得到一对反、顺异构体,两者的比例约为15:1。并确定反式的四氢化物具有扭船式构象,顺式的四氢化物具有椅式构象。     

微波辐射下合成3-芳基-9-氨基-1,2,3,4-四氢吖啶-1-酮衍生物

在微波辐射和对甲基苯磺酸的催化作用下, 5-芳基-1,3-环己二酮与邻氨基苯甲腈进行缩合反应, 得到了N-取代的2-氨基苯甲腈衍生物, 在K₂CO₃和Cu₂Cl₂的催化作用下进一步合环, 得到3-芳基-9-氨基-1,2,3,4-四氢吖啶-1-酮衍生物, 用LiAlH₄还原羰基得到3-芳基-9-氨基-1,2,3,4-四氢吖啶-1-醇衍生物. 新合成化合物的结构均经元素分析、红外光谱和核磁共振光谱予以确认.     

2,3,8,9-四氢吡啶并[2,3-d:6,5-d’]二嘧啶-4,6-二酮衍生物的合成

以丙二腈、原羧酸三乙酯、吡啶为起始原料经环化、氨解,然后与酮在甲醇钠催化下反应得到了2,3,8,9-四氢吡啶并[2,3-d:6,5-d’]二嘧啶-4,6-二酮衍生物.目标产物的结构经IR,NMR,ESI和元素分析确证.     

6,7-亚甲二氧基-3-硫杂-1(2H,4H)吖啶酮的氨类衍生物及五元杂环并硫杂吖啶的合成

吖啶类化合物在抗疟和抗癌的药用研究中具有显著的作用[1,2],尤其在临床抗疟中广泛地应用了该类药物.为了深入进行吖啶化学的     

7-(羟甲基)-8-氮杂螺[4.5]癸烷-8-羧酸叔丁酯的合成

以8-氮杂螺[4.5]癸烷-7,9-二酮为原料,通过酰胺还原、N-Boc保护、甲酰化、醛基四步反应还原反应合成得到目标化合物7-(羟甲基)-8-氮杂螺[4.5]癸烷-8-羧酸叔丁酯,总收率29.8％.反应中间体及产物结构经1 H NMR和ESI-MS确证,同时对每步反应条件进行讨论.该研究提供了一种新结构的含氮螺环化合...     

Ultrasound-Promoted One-Pot Synthesis of 7-Aryl-7,10,11,12-tetrahydrobenzo[c]acridin-8(9H)-one Derivatives

A series of 7-aryl-7,10,11,12-tetrahydrobenzo[c]acridin-8(9H)-one derivatives were synthesized via the three-component coupling from aromatic aldehydes, 1-naphthylamine, and 5,5-dimethylcyclohexane-1,3-dione catalyzed by stannous chloride dihydrate (SnCl₂ · 2H₂O) under ultrasonic irradiation at room temperature. The products were isolated in good yields within short reaction times.      

(1R,2S,5R,8S,9R,10S)-8-甲基-4-氮杂-5-苯基-7-氧杂四环[8.2.1.0~(2,9).0(~4,8)]十三-11-烯-3-酮的合成和晶体结构

为确定内型降冰片烯酰亚胺与甲基格氏试剂反应所得加成产物的结构,合成了标题化合物(C18H19NO2)。其结构通过单晶X-射线衍射分析确定,该晶体属正交晶系,空间群为P212121,a = 6.293(1),b = 14.342(3),c = 16.357(3) 牛琕 = 1476.2(5) ?,Z = 4,Dc = 1.266 g/cm3, (MoKa) = 0.082mm-1,F(000) = 600。晶体结构用直接法解出,最终的偏离因子为R = 0.0535,wR = 0.988。由此晶体结构可确定加成产物为标题化合物,并由1H-NMR数据推测另一加成产物的结构。     

Synthesis of 7-[4-alkoxy-3-methoxy(hydroxy)phenyl]-10,11-dihydrobenzo[c]acridin-8(7H,9H,12H)-ones and 4-(8-oxo-7,8,9,10,11,12-hexahydrobenzo[c]acridin-7-yl)-2-methoxy(ethoxy)phenyl esters of carboxylic acids

Reactions of azomethines (Schiff bases) prepared from vanillin and vanillal ethers and 1-naphthylamine with cyclohexane-1,3-dione in butanol afforded in 40–64% yields 7-[4-alkoxy-3-methoxy(hydroxy)phenyl]-10,11-dihydrobenzo[c]acridin-8(7H,9H,12H)-ones and 4-(8-oxo-7,8,9,10,11,12-hexahydrobenzo[C]acridin-7-yl)-2-methoxy(ethoxy)phenyl esters of carboxylic acids. The reaction products presumably formed by the rearrangement of the azomethine adduct with the cyclohexane-1,3-dione proceeding by the type of Hofmann-Martius rearrangement. The structure of compounds synthesized was confirmed by the elemental analysis, UV, IR, and ¹H NMR spectra.     

Synthesis of 11-hydroxydrim-8(9)-en-7-one and 11,12-dihydroxydrim-8(9)-en-7-one from drim-8(9)-en-7-one

A synthetic route to 11-hydroxydrim-8(9)-en-7-one and 11,12-hydroxydrim-8(9)-en-7-one, valuable key intermediates for the preparation of naturally occurring biologically active drimanic sesquiterpenoids, starting from easily available drim-8(9)-en-7-one was developed. 11-Hydroxydrim-8(9)-en-7-one was obtained by peracidic oxidation of the enol acetate of drim-8(9)-en-7-one. 11,12-Dihydroxydrim-8(9)-en-7-one was synthesized from drim-8(9)-en-7-one by two routes, namely, by a five-step procedurevia 11-hydroxydrim-8(9)-en-7-one and by bromination of drim-8(9)-en-7-one with NBS to give 11,12-dibromodrim-8(9)-en-7-one followed by its acetoxylation and deacetylation. Deceased Translated fromIzvestiya Akademii Nauk, Seriya Khimicheskaya, No. 1, pp. 95–98, January, 2000.     

Synthesis of 11-hydroxydrim-8(9)-en-7-one and 11,12-dihydroxydrim-8(9)-en-7-one from drim-8(9)-en-7-one

A synthetic route to 11-hydroxydrim-8(9)-en-7-one and 11,12-hydroxydrim-8(9)-en-7-one, valuable key intermediates for the preparation of naturally occurring biologically active drimanic sesquiterpenoids, starting from easily available drim-8(9)-en-7-one was developed. 11-Hydroxydrim-8(9)-en-7-one was obtained by peracidic oxidation of the enol acetate of drim-8(9)-en-7-one. 11,12-Dihydroxydrim-8(9)-en-7-one was synthesized from drim-8(9)-en-7-one by two routes, namely, by a five-step procedurevia 11-hydroxydrim-8(9)-en-7-one and by bromination of drim-8(9)-en-7-one with NBS to give 11,12-dibromodrim-8(9)-en-7-one followed by its acetoxylation and deacetylation. Deceased Translated fromIzvestiya Akademii Nauk, Seriya Khimicheskaya, No. 1, pp. 95–98, January, 2000.     

Heterocyclic compounds from 3-(4-phenyl) benzoyl propionic acid

3-(4-Phenyl) benzoyl propionic acid was used as the starting material for the synthesisof furanones (2), pyrrolinones (5), pyridazinones (7), benzoxazinones (8) and quinazolinones (9-11). The behaviour of the derivatives of furanones and benzoxazinones toward different nucleophiles is reported.     

6,7-亚甲二氧基-9-甲基-1(2H,4H)-吖啶酮衍生物的合成

以5-芳基-1,3-环基环己二酮为原料合成了8个未见报道的吖啶酮衍生物,其结构均经元素分析,IR和^1H NMR光谱确证。其中3-呋喃基-6,7-亚甲二氧基-9-甲基-1(2H,4H)-吖啶醇对一些肿瘤细胞有抑制作用。